NCT02921256 Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE2
NCT02918747 PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage Status UNKNOWN Phase PHASE2
NCT02912559 Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02904031 Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly Patients Status UNKNOWN Phase PHASE2
NCT02896907 Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase EARLY_PHASE1
NCT02879227 Radiochemotherapy in Elderly Patients With Oesophagus Cancer Status COMPLETED Phase PHASE2
NCT02872116 Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer Status COMPLETED Phase PHASE3
NCT02864849 Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer Status COMPLETED Phase PHASE2
NCT02862535 Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma Status TERMINATED Phase PHASE1
NCT02860234 Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment Status COMPLETED Phase N/A
NCT02856867 Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN) Status WITHDRAWN Phase PHASE2
NCT02848443 Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT02845986 Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer Status UNKNOWN Phase PHASE2
NCT02842580 De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT02833753 Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI Status COMPLETED Phase PHASE1
NCT02785146 Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT02767674 Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma Status UNKNOWN Phase PHASE3
NCT02745561 Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients. Status UNKNOWN Phase PHASE2
NCT02741388 A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP Status COMPLETED Phase PHASE1